|
|
| | L-Methionine, L-threonyl-L-prolyl-L-arginyl-L-valyl-L-threonylglycylglycylglycyl-L-alanyl- Basic information |
| | L-Methionine, L-threonyl-L-prolyl-L-arginyl-L-valyl-L-threonylglycylglycylglycyl-L-alanyl- Chemical Properties |
| density | 1.50±0.1 g/cm3(Predicted) | | pka | 3.24±0.10(Predicted) | | Sequence | Thr-Pro-Arg-Val-Thr-Gly-Gly-Gly-Ala-Met |
| | L-Methionine, L-threonyl-L-prolyl-L-arginyl-L-valyl-L-threonylglycylglycylglycyl-L-alanyl- Usage And Synthesis |
| Uses | CMV pp65 (415-429) is a CEF control peptide that is derived from the Cytomegalovirus (CMV)[1]. | | References | [1] Peggs K, et al. Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. Blood. 2002 Jan 1;99(1):213-23. DOI:10.1182/blood.v99.1.213 |
| | L-Methionine, L-threonyl-L-prolyl-L-arginyl-L-valyl-L-threonylglycylglycylglycyl-L-alanyl- Preparation Products And Raw materials |
|